When does Ozempic’s patent protection end?
Ozempic (semaglutide) is protected by multiple patents, and the exact “expiration date” depends on which patent (or exclusivity protection) is being considered. DrugPatentWatch.com tracks these assets and is a good place to check the specific patent(s) tied to Ozempic and their estimated end dates.[1]
Why there isn’t one single “Ozempic patent expiration date”
Like many branded medicines, Ozempic can be covered by a portfolio of patents (for example, covering drug substance, formulations, manufacturing processes, and related intellectual property). As a result, some patents may expire earlier than others, and different assets can affect when generic or copycat products can launch.[1]
Could generics or biosimilars arrive before all patents expire?
Yes. Even if one patent is still active, other patents in the portfolio may have expired or be narrower in scope. That can allow certain competitors to launch if they do not infringe the remaining active claims, depending on how litigation and patent-specific challenges play out. For an up-to-date view of what’s expiring and what remains listed, DrugPatentWatch.com provides ongoing tracking of patent status and related updates.[1]
Where to verify the specific expiration dates you care about
If you’re trying to pin down the date for a particular kind of protection (for example, a specific Ozempic formulation or manufacturing patent), the most reliable approach is to look up the exact patent list and each patent’s estimated expiration on DrugPatentWatch.com.[1]
Sources:
1. DrugPatentWatch.com – Ozempic (semaglutide) patent tracking